{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T03:44:31Z","timestamp":1780371871597,"version":"3.54.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,5,11]]},"DOI":"10.7759\/cureus.38907","type":"journal-article","created":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T23:56:37Z","timestamp":1683849397000},"source":"Crossref","is-referenced-by-count":1,"title":["Ampreloxetine Versus Droxidopa in Neurogenic Orthostatic Hypotension: A Comparative Review"],"prefix":"10.7759","author":[{"given":"Pranvera","family":"Hoxhaj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shruti","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica E","family":"Muyolema Arce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wajiha","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirali","family":"Sadeghzadegan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saumya","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaudy F","family":"Collado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imran","family":"Khawaja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepti","family":"Botlaguduru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waleed","family":"Razzaq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zain U","family":"Abdin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ishita","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.15586\/codonpublications.parkinsonsdisease.2018","article-title":"Parkinson\u2019s Disease: Pathogenesis and Clinical Aspects [Internet]","year":"2018","unstructured":"Parkinson\u2019s Disease. Pathogenesis and Clinical Aspects [Internet]. Stoker TB, Greenland JC (ed): Codon Publications, Brisbane, AU; 2018. 10.15586\/codonpublications.parkinsonsdisease.2018"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.13691","article-title":"The clinical symptoms of Parkinson's disease","volume":"139","author":"Sveinbjornsdottir S","year":"2016","unstructured":"Sveinbjornsdottir S. The clinical symptoms of Parkinson's disease. J Neurochem. 2016, 139:318-24. 10.1111\/jnc.13691","journal-title":"J Neurochem"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1289\/ehp.1306967","article-title":"Research on the premotor symptoms of Parkinson\u2019s disease: clinical and etiological implications","volume":"121","author":"Chen H","year":"2013","unstructured":"Chen H, Burton EA, Ross GW, et al.. Research on the premotor symptoms of Parkinson\u2019s disease: clinical and etiological implications. Environ Health Perspect. 2013, 121:1245-52. 10.1289\/ehp.1306967","journal-title":"Environ Health Perspect"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.cger.2019.09.002","article-title":"Orthostatic hypotension in Parkinson disease","volume":"36","author":"Palma JA","year":"2020","unstructured":"Palma JA, Kaufmann H. Orthostatic hypotension in Parkinson disease. Clin Geriatr Med. 2020, 36:53-67. 10.1016\/j.cger.2019.09.002","journal-title":"Clin Geriatr Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s10286-011-0119-5","article-title":"Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome","volume":"21","author":"Freeman R","year":"2011","unstructured":"Freeman R, Wieling W, Axelrod FB, et al.. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res. 2011, 21:69-72. 10.1007\/s10286-011-0119-5","journal-title":"Clin Auton Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2003.029413","article-title":"Frequency of orthostatic hypotension in a community based cohort of patients with Parkinson's disease","volume":"75","author":"Allcock LM","year":"2004","unstructured":"Allcock LM, Ullyart K, Kenny RA, Burn DJ. Frequency of orthostatic hypotension in a community based cohort of patients with Parkinson's disease. J Neurol Neurosurg Psychiatry. 2004, 75:1470-1. 10.1136\/jnnp.2003.029413","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2006.01512.x","article-title":"EFNS guidelines on the diagnosis and management of orthostatic hypotension","volume":"13","author":"Lahrmann H","year":"2006","unstructured":"Lahrmann H, Cortelli P, Hilz M, Mathias CJ, Struhal W, Tassinari M. EFNS guidelines on the diagnosis and management of orthostatic hypotension. Eur J Neurol. 2006, 13:930-6. 10.1111\/j.1468-1331.2006.01512.x","journal-title":"Eur J Neurol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30295-3","article-title":"Global, regional, and national burden of Parkinson's disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"17","author":"GBD 2016 Parkinson's Disease Collaborators","year":"2018","unstructured":"GBD 2016 Parkinson's Disease Collaborators. Global, regional, and national burden of Parkinson's disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018, 17:939-53. 10.1016\/S1474-4422(18)30295-3","journal-title":"Lancet Neurol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2011.04.016","article-title":"Prevalence of orthostatic hypotension in Parkinson's disease: a systematic review and meta-analysis","volume":"17","author":"Velseboer DC","year":"2011","unstructured":"Velseboer DC, de Haan RJ, Wieling W, Goldstein DS, de Bie RM. Prevalence of orthostatic hypotension in Parkinson's disease: a systematic review and meta-analysis. Parkinsonism Relat Disord. 2011, 17:724-9. 10.1016\/j.parkreldis.2011.04.016","journal-title":"Parkinsonism Relat Disord"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/mdc3.12478","article-title":"Epidemiology, diagnosis, and management of neurogenic orthostatic hypotension","volume":"4","author":"Palma JA","year":"2017","unstructured":"Palma JA, Kaufmann H. Epidemiology, diagnosis, and management of neurogenic orthostatic hypotension. Mov Disord Clin Pract. 2017, 4:298-308. 10.1002\/mdc3.12478","journal-title":"Mov Disord Clin Pract"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000125192.69777.6d","article-title":"Autonomic dysfunction in dementia with Lewy bodies","volume":"62","author":"Thaisetthawatkul P","year":"2004","unstructured":"Thaisetthawatkul P, Boeve BF, Benarroch EE, Sandroni P, Ferman TJ, Petersen R, Low PA. Autonomic dysfunction in dementia with Lewy bodies. Neurology. 2004, 62:1804-9. 10.1212\/01.wnl.0000125192.69777.6d","journal-title":"Neurology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26079","article-title":"Orthostatic hypotension in Parkinson disease: how much you fall or how low you go?","volume":"30","author":"Palma JA","year":"2015","unstructured":"Palma JA, Gomez-Esteban JC, Norcliffe-Kaufmann L, Martinez J, Tijero B, Berganzo K, Kaufmann H. Orthostatic hypotension in Parkinson disease: how much you fall or how low you go?. Mov Disord. 2015, 30:639-45. 10.1002\/mds.26079","journal-title":"Mov Disord"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.5114\/ninp.2013.38222","article-title":"Causes and consequences of falls in Parkinson disease patients in a prospective study","volume":"47","author":"Rudzi\u0144ska M","year":"2013","unstructured":"Rudzi\u0144ska M, Bukowczan S, Sto\u017cek J, et al.. Causes and consequences of falls in Parkinson disease patients in a prospective study. Neurol Neurochir Pol. 2013, 47:423-30. 10.5114\/ninp.2013.38222","journal-title":"Neurol Neurochir Pol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/mds.21956","article-title":"The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years","volume":"23","author":"Hely MA","year":"2008","unstructured":"Hely MA, Reid WG, Adena MA, Halliday GM, Morris JG. The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years. Mov Disord. 2008, 23:837-44. 10.1002\/mds.21956","journal-title":"Mov Disord"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s40120-019-00152-9","article-title":"Neurogenic orthostatic hypotension in Parkinson disease: a primer","volume":"8","author":"Cutsforth-Gregory JK","year":"2019","unstructured":"Cutsforth-Gregory JK, Low PA. Neurogenic orthostatic hypotension in Parkinson disease: a primer. Neurol Ther. 2019, 8:307-24. 10.1007\/s40120-019-00152-9","journal-title":"Neurol Ther"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.14336\/AD.2019.0805","article-title":"Parkinson disease and orthostatic hypotension in the elderly: recognition and management of risk factors for falls","volume":"11","author":"LeWitt PA","year":"2020","unstructured":"LeWitt PA, Kymes S, Hauser RA. Parkinson disease and orthostatic hypotension in the elderly: recognition and management of risk factors for falls. Aging Dis. 2020, 11:679-91. 10.14336\/AD.2019.0805","journal-title":"Aging Dis"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3233\/JPD-202036","article-title":"Management of orthostatic hypotension in Parkinson's disease","volume":"10","author":"Fanciulli A","year":"2020","unstructured":"Fanciulli A, Leys F, Falup-Pecurariu C, Thijs R, Wenning GK. Management of orthostatic hypotension in Parkinson's disease. J Parkinsons Dis. 2020, 10:S57-64. 10.3233\/JPD-202036","journal-title":"J Parkinsons Dis"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s10286-021-00827-0","article-title":"Safety and efficacy of ampreloxetine in symptomatic neurogenic orthostatic hypotension: a phase 2 trial","volume":"31","author":"Kaufmann H","year":"2021","unstructured":"Kaufmann H, Vickery R, Wang W, et al.. Safety and efficacy of ampreloxetine in symptomatic neurogenic orthostatic hypotension: a phase 2 trial. Clin Auton Res. 2021, 31:699-711. 10.1007\/s10286-021-00827-0","journal-title":"Clin Auton Res"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3233\/JPD-160860","article-title":"Safety and durability of effect with Long-term, open-label droxidopa treatment in patients with symptomatic neurogenic orthostatic hypotension (NOH303)","volume":"6","author":"Isaacson S","year":"2016","unstructured":"Isaacson S, Shill HA, Vernino S, Ziemann A, Rowse GJ. Safety and durability of effect with Long-term, open-label droxidopa treatment in patients with symptomatic neurogenic orthostatic hypotension (NOH303). J Parkinsons Dis. 2016, 6:751-9. 10.3233\/JPD-160860","journal-title":"J Parkinsons Dis"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3233\/JPD-130259","article-title":"Droxidopa in patients with neurogenic orthostatic hypotension associated with Parkinson's disease (NOH306A)","volume":"4","author":"Hauser RA","year":"2014","unstructured":"Hauser RA, Hewitt LA, Isaacson S. Droxidopa in patients with neurogenic orthostatic hypotension associated with Parkinson's disease (NOH306A). J Parkinsons Dis. 2014, 4:57-65. 10.3233\/JPD-130259","journal-title":"J Parkinsons Dis"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26086","article-title":"Droxidopa for the short-term treatment of symptomatic neurogenic orthostatic hypotension in Parkinson's disease (nOH306B)","volume":"30","author":"Hauser RA","year":"2015","unstructured":"Hauser RA, Isaacson S, Lisk JP, Hewitt LA, Rowse G. Droxidopa for the short-term treatment of symptomatic neurogenic orthostatic hypotension in Parkinson's disease (nOH306B). Mov Disord. 2015, 30:646-54. 10.1002\/mds.26086","journal-title":"Mov Disord"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jash.2016.07.009","article-title":"Effects of the novel norepinephrine prodrug, droxidopa, on ambulatory blood pressure in patients with neurogenic orthostatic hypotension","volume":"10","author":"Kaufmann H","year":"2016","unstructured":"Kaufmann H, Norcliffe-Kaufmann L, Hewitt LA, Rowse GJ, White WB. Effects of the novel norepinephrine prodrug, droxidopa, on ambulatory blood pressure in patients with neurogenic orthostatic hypotension. J Am Soc Hypertens. 2016, 10:819-26. 10.1016\/j.jash.2016.07.009","journal-title":"J Am Soc Hypertens"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-017-0867-5","article-title":"Integrated analysis of droxidopa trials for neurogenic orthostatic hypotension","volume":"17","author":"Biaggioni I","year":"2017","unstructured":"Biaggioni I, Hewitt LA, Rowse GJ, Kaufmann H. Integrated analysis of droxidopa trials for neurogenic orthostatic hypotension. BMC Neurol. 2017, 17:90. 10.1186\/s12883-017-0867-5","journal-title":"BMC Neurol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1097\/WNF.0000000000000168","article-title":"Droxidopa and reduced falls in a trial of Parkinson disease patients with neurogenic orthostatic hypotension","volume":"39","author":"Hauser RA","year":"2016","unstructured":"Hauser RA, Heritier S, Rowse GJ, Hewitt LA, Isaacson SH. Droxidopa and reduced falls in a trial of Parkinson disease patients with neurogenic orthostatic hypotension. Clin Neuropharmacol. 2016, 39:220-6. 10.1097\/WNF.0000000000000168","journal-title":"Clin Neuropharmacol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000615","article-title":"Droxidopa for neurogenic orthostatic hypotension: a randomized, placebo-controlled, phase 3 trial","volume":"83","author":"Kaufmann H","year":"2014","unstructured":"Kaufmann H, Freeman R, Biaggioni I, et al.. Droxidopa for neurogenic orthostatic hypotension: a randomized, placebo-controlled, phase 3 trial. Neurology. 2014, 83:328-35. 10.1212\/WNL.0000000000000615","journal-title":"Neurology"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.114.04035","article-title":"Randomized withdrawal study of patients with symptomatic neurogenic orthostatic hypotension responsive to droxidopa","volume":"65","author":"Biaggioni I","year":"2015","unstructured":"Biaggioni I, Freeman R, Mathias CJ, Low P, Hewitt LA, Kaufmann H. Randomized withdrawal study of patients with symptomatic neurogenic orthostatic hypotension responsive to droxidopa. Hypertension. 2015, 65:101-7. 10.1161\/HYPERTENSIONAHA.114.04035","journal-title":"Hypertension"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1007\/s10286-021-00800-x","article-title":"Pharmacokinetics and pharmacodynamics of ampreloxetine, a novel, selective norepinephrine reuptake inhibitor, in symptomatic neurogenic orthostatic hypotension","volume":"31","author":"Lo A","year":"2021","unstructured":"Lo A, Norcliffe-Kaufmann L, Vickery R, Bourdet D, Kanodia J. Pharmacokinetics and pharmacodynamics of ampreloxetine, a novel, selective norepinephrine reuptake inhibitor, in symptomatic neurogenic orthostatic hypotension. Clin Auton Res. 2021, 31:395-403. 10.1007\/s10286-021-00800-x","journal-title":"Clin Auton Res"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2011.10.025","article-title":"Cardiovascular dysautonomia in Parkinson disease: from pathophysiology to pathogenesis","volume":"46","author":"Jain S","year":"2012","unstructured":"Jain S, Goldstein DS. Cardiovascular dysautonomia in Parkinson disease: from pathophysiology to pathogenesis. Neurobiol Dis. 2012, 46:572-80. 10.1016\/j.nbd.2011.10.025","journal-title":"Neurobiol Dis"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1509723","article-title":"Baroreflex dysfunction","volume":"382","author":"Kaufmann H","year":"2020","unstructured":"Kaufmann H, Norcliffe-Kaufmann L, Palma JA. Baroreflex dysfunction. N Engl J Med. 2020, 382:163-78. 10.1056\/NEJMra1509723","journal-title":"N Engl J Med"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/hpaa131","article-title":"Neurogenic orthostatic hypotension. Lessons from synucleinopathies","volume":"34","author":"Idiaquez JF","year":"2021","unstructured":"Idiaquez JF, Idiaquez J, Casar JC, Biaggioni I. Neurogenic orthostatic hypotension. Lessons from synucleinopathies. Am J Hypertens. 2021, 34:125-33. 10.1093\/ajh\/hpaa131","journal-title":"Am J Hypertens"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.05.079","article-title":"Orthostatic hypotension: JACC state-of-the-art review","volume":"72","author":"Freeman R","year":"2018","unstructured":"Freeman R, Abuzinadah AR, Gibbons C, Jones P, Miglis MG, Sinn DI. Orthostatic hypotension: JACC state-of-the-art review. J Am Coll Cardiol. 2018, 72:1294-309. 10.1016\/j.jacc.2018.05.079","journal-title":"J Am Coll Cardiol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-010-0664-3","article-title":"Multi-organ distribution of phosphorylated \u03b1-synuclein histopathology in subjects with Lewy body disorders","volume":"119","author":"Beach TG","year":"2010","unstructured":"Beach TG, Adler CH, Sue LI, et al.. Multi-organ distribution of phosphorylated \u03b1-synuclein histopathology in subjects with Lewy body disorders. Acta Neuropathol. 2010, 119:689-702. 10.1007\/s00401-010-0664-3","journal-title":"Acta Neuropathol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1111\/j.1750-3639.2005.tb00097.x","article-title":"Profound cardiac sympathetic denervation occurs in Parkinson disease","volume":"15","author":"Amino T","year":"2005","unstructured":"Amino T, Orimo S, Itoh Y, Takahashi A, Uchihara T, Mizusawa H. Profound cardiac sympathetic denervation occurs in Parkinson disease. Brain Pathol. 2005, 15:29-34. 10.1111\/j.1750-3639.2005.tb00097.x","journal-title":"Brain Pathol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-016-8375-x","article-title":"The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension","volume":"264","author":"Gibbons CH","year":"2017","unstructured":"Gibbons CH, Schmidt P, Biaggioni I, et al.. The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension. J Neurol. 2017, 264:1567-82. 10.1007\/s00415-016-8375-x","journal-title":"J Neurol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000005994","article-title":"The efficacy of nonpharmacologic intervention for orthostatic hypotension associated with aging","volume":"91","author":"Newton JL","year":"2018","unstructured":"Newton JL, Frith J. The efficacy of nonpharmacologic intervention for orthostatic hypotension associated with aging. Neurology. 2018, 91:e652-6. 10.1212\/WNL.0000000000005994","journal-title":"Neurology"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1007\/s10286-004-0187-x","article-title":"Use of lower abdominal compression to combat orthostatic hypotension in patients with autonomic dysfunction","volume":"14","author":"Smit AA","year":"2004","unstructured":"Smit AA, Wieling W, Fujimura J, et al.. Use of lower abdominal compression to combat orthostatic hypotension in patients with autonomic dysfunction. Clin Auton Res. 2004, 14:167-75. 10.1007\/s10286-004-0187-x","journal-title":"Clin Auton Res"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.apmr.2014.09.028","article-title":"Nonpharmacologic management of orthostatic hypotension: a systematic review","volume":"96","author":"Mills PB","year":"2015","unstructured":"Mills PB, Fung CK, Travlos A, Krassioukov A. Nonpharmacologic management of orthostatic hypotension: a systematic review. Arch Phys Med Rehabil. 2015, 96:366-75. 10.1016\/j.apmr.2014.09.028","journal-title":"Arch Phys Med Rehabil"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.4065\/71.9.847","article-title":"Role of physical countermaneuvers in the management of orthostatic hypotension: efficacy and biofeedback augmentation","volume":"71","author":"Bouvette CM","year":"1996","unstructured":"Bouvette CM, McPhee BR, Opfer-Gehrking TL, Low PA. Role of physical countermaneuvers in the management of orthostatic hypotension: efficacy and biofeedback augmentation. Mayo Clin Proc. 1996, 71:847-53. 10.4065\/71.9.847","journal-title":"Mayo Clin Proc"},{"key":"ref39","article-title":"Orthostatic hypotension. A primary care primer for assessment and treatment","volume":"59","author":"Sclater A","year":"2004","unstructured":"Sclater A, Alagiakrishnan K. Orthostatic hypotension. A primary care primer for assessment and treatment. Geriatrics. 2004, 59:22-7.","journal-title":"Geriatrics"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(08)70088-7","article-title":"Management of neurogenic orthostatic hypotension: an update","volume":"7","author":"Low PA","year":"2008","unstructured":"Low PA, Singer W. Management of neurogenic orthostatic hypotension: an update. Lancet Neurol. 2008, 7:451-8. 10.1016\/S1474-4422(08)70088-7","journal-title":"Lancet Neurol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-014-0342-1","article-title":"Droxidopa: a review of its use in symptomatic neurogenic orthostatic hypotension","volume":"75","author":"Keating GM","year":"2015","unstructured":"Keating GM. Droxidopa: a review of its use in symptomatic neurogenic orthostatic hypotension. Drugs. 2015, 75:197-206. 10.1007\/s40265-014-0342-1","journal-title":"Drugs"},{"key":"ref42","unstructured":"PubChem Compound Summary for CID 12699, N-Nitroso-N-methylurea. (2020). Accessed. March 24, 2023: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/N-Nitroso-N-methylurea."},{"key":"ref43","unstructured":"PubChem Compound Summary for CID 92974, Droxidopa. (2023). Accessed. March 17, 2023: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Droxidopa."},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1007\/s10286-007-1002-2","article-title":"L-dihydroxyphenylserine (droxidopa): a new therapy for neurogenic orthostatic hypotension: the US experience","volume":"18","author":"Kaufmann H","year":"2008","unstructured":"Kaufmann H. L-dihydroxyphenylserine (droxidopa): a new therapy for neurogenic orthostatic hypotension: the US experience. Clin Auton Res. 2008, 18:19-24. 10.1007\/s10286-007-1002-2","journal-title":"Clin Auton Res"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.3390\/life12091393","article-title":"L-DOPA and droxidopa: from force field development to molecular docking into human \u03b2(2)-adrenergic receptor","volume":"12","author":"Catte A","year":"2022","unstructured":"Catte A, Biswas AD, Mancini G, Barone V. L-DOPA and droxidopa: from force field development to molecular docking into human \u03b2(2)-adrenergic receptor. Life (Basel). 2022, 12:1393. 10.3390\/life12091393","journal-title":"Life (Basel)"},{"key":"ref46","article-title":"LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]","year":"2012","unstructured":"LiverTox. Clinical and Research Information on Drug-Induced Liver Injury [Internet]. National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD; 2012."},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.107.089961","article-title":"Norepinephrine transporter blockade with atomoxetine induces hypertension in patients with impaired autonomic function","volume":"50","author":"Shibao C","year":"2007","unstructured":"Shibao C, Raj SR, Gamboa A, et al.. Norepinephrine transporter blockade with atomoxetine induces hypertension in patients with impaired autonomic function. Hypertension. 2007, 50:47-53. 10.1161\/HYPERTENSIONAHA.107.089961","journal-title":"Hypertension"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-020-00918-7","article-title":"Pharmacokinetics of ampreloxetine, a norepinephrine reuptake inhibitor, in healthy subjects and adults with attention-deficit\/hyperactive disorder or fibromyalgia pain","volume":"60","author":"Kanodia J","year":"2021","unstructured":"Kanodia J, Lo A, Baldwin RM, Graham RA, Bourdet DL. Pharmacokinetics of ampreloxetine, a norepinephrine reuptake inhibitor, in healthy subjects and adults with attention-deficit\/hyperactive disorder or fibromyalgia pain. Clin Pharmacokinet. 2021, 60:121-31. 10.1007\/s40262-020-00918-7","journal-title":"Clin Pharmacokinet"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.109.136853","article-title":"Renal impairment of pure autonomic failure","volume":"54","author":"Garland EM","year":"2009","unstructured":"Garland EM, Gamboa A, Okamoto L, et al.. Renal impairment of pure autonomic failure. Hypertension. 2009, 54:1057-61. 10.1161\/HYPERTENSIONAHA.109.136853","journal-title":"Hypertension"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1311488","article-title":"Multiple-system atrophy","volume":"372","author":"Fanciulli A","year":"2015","unstructured":"Fanciulli A, Wenning GK. Multiple-system atrophy. N Engl J Med. 2015, 372:249-63. 10.1056\/NEJMra1311488","journal-title":"N Engl J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/147733-ampreloxetine-versus-droxidopa-in-neurogenic-orthostatic-hypotension-a-comparative-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:59:41Z","timestamp":1707508781000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/147733-ampreloxetine-versus-droxidopa-in-neurogenic-orthostatic-hypotension-a-comparative-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,11]]},"references-count":50,"URL":"https:\/\/doi.org\/10.7759\/cureus.38907","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5,11]]}}}